Annual D&A
$1.10 M
+$115.00 K+11.70%
31 December 2023
Summary:
Crinetics Pharmaceuticals annual depreciation & amortization is currently $1.10 million, with the most recent change of +$115.00 thousand (+11.70%) on 31 December 2023. During the last 3 years, it has risen by +$176.00 thousand (+19.09%). CRNX annual D&A is now at all-time high.CRNX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$770.00 K
+$17.00 K+2.26%
30 September 2024
Summary:
Crinetics Pharmaceuticals quarterly depreciation & amortization is currently $770.00 thousand, with the most recent change of +$17.00 thousand (+2.26%) on 30 September 2024. Over the past year, it has increased by +$508.00 thousand (+193.89%). CRNX quarterly D&A is now at all-time high.CRNX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$2.26 M
+$497.00 K+28.21%
30 September 2024
Summary:
Crinetics Pharmaceuticals TTM depreciation & amortization is currently $2.26 million, with the most recent change of +$497.00 thousand (+28.21%) on 30 September 2024. Over the past year, it has increased by +$1.16 million (+105.74%). CRNX TTM D&A is now at all-time high.CRNX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRNX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +193.9% | +105.7% |
| 3 y3 years | +19.1% | +227.7% | +145.0% |
| 5 y5 years | +23.8% | +236.2% | +154.7% |
CRNX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +19.1% | at high | +258.1% | at high | +145.0% |
| 5 y | 5 years | at high | +23.8% | at high | +258.1% | at high | +154.7% |
| alltime | all time | at high | +1093.5% | at high | +2980.0% | at high | +8266.7% |
Crinetics Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $770.00 K(+2.3%) | $2.26 M(+28.2%) |
| June 2024 | - | $753.00 K(+58.9%) | $1.76 M(+36.7%) |
| Mar 2024 | - | $474.00 K(+80.9%) | $1.29 M(+17.4%) |
| Dec 2023 | $1.10 M(+11.7%) | $262.00 K(-4.0%) | $1.10 M(-1.6%) |
| Sept 2023 | - | $273.00 K(-2.5%) | $1.12 M(+2.3%) |
| June 2023 | - | $280.00 K(-1.1%) | $1.09 M(+6.3%) |
| Mar 2023 | - | $283.00 K(+1.1%) | $1.03 M(+4.4%) |
| Dec 2022 | $983.00 K(+6.6%) | $280.00 K(+12.9%) | $983.00 K(+4.8%) |
| Sept 2022 | - | $248.00 K(+15.3%) | $938.00 K(+1.6%) |
| June 2022 | - | $215.00 K(-10.4%) | $923.00 K(-1.6%) |
| Mar 2022 | - | $240.00 K(+2.1%) | $938.00 K(+1.7%) |
| Dec 2021 | $922.00 K(-2.7%) | $235.00 K(+0.9%) | $922.00 K(+1.1%) |
| Sept 2021 | - | $233.00 K(+1.3%) | $912.00 K(-1.2%) |
| June 2021 | - | $230.00 K(+2.7%) | $923.00 K(-1.5%) |
| Mar 2021 | - | $224.00 K(-0.4%) | $937.00 K(-1.2%) |
| Dec 2020 | $948.00 K | $225.00 K(-7.8%) | $948.00 K(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $244.00 K(0.0%) | $952.00 K(+1.7%) |
| June 2020 | - | $244.00 K(+3.8%) | $936.00 K(+1.5%) |
| Mar 2020 | - | $235.00 K(+2.6%) | $922.00 K(+3.9%) |
| Dec 2019 | $887.00 K(+88.3%) | $229.00 K(+0.4%) | $887.00 K(+2.4%) |
| Sept 2019 | - | $228.00 K(-0.9%) | $866.00 K(+11.5%) |
| June 2019 | - | $230.00 K(+15.0%) | $777.00 K(+24.7%) |
| Mar 2019 | - | $200.00 K(-3.8%) | $623.00 K(+32.3%) |
| Dec 2018 | $471.00 K(+268.0%) | $208.00 K(+49.6%) | $471.00 K(+51.4%) |
| Sept 2018 | - | $139.00 K(+82.9%) | $311.00 K(+55.5%) |
| June 2018 | - | $76.00 K(+58.3%) | $200.00 K(+34.2%) |
| Mar 2018 | - | $48.00 K(0.0%) | $149.00 K(+16.4%) |
| Dec 2017 | $128.00 K(+39.1%) | $48.00 K(+71.4%) | $128.00 K(+60.0%) |
| Sept 2017 | - | $28.00 K(+12.0%) | $80.00 K(+53.8%) |
| June 2017 | - | $25.00 K(-7.4%) | $52.00 K(+92.6%) |
| Mar 2017 | - | $27.00 K | $27.00 K |
| Dec 2016 | $92.00 K | - | - |
FAQ
- What is Crinetics Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly D&A year-on-year change?
- What is Crinetics Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals TTM D&A year-on-year change?
What is Crinetics Pharmaceuticals annual depreciation & amortization?
The current annual D&A of CRNX is $1.10 M
What is the all time high annual D&A for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual depreciation & amortization is $1.10 M
What is Crinetics Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of CRNX is $770.00 K
What is the all time high quarterly D&A for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly depreciation & amortization is $770.00 K
What is Crinetics Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, CRNX quarterly depreciation & amortization has changed by +$508.00 K (+193.89%)
What is Crinetics Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of CRNX is $2.26 M
What is the all time high TTM D&A for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high TTM depreciation & amortization is $2.26 M
What is Crinetics Pharmaceuticals TTM D&A year-on-year change?
Over the past year, CRNX TTM depreciation & amortization has changed by +$1.16 M (+105.74%)